✦ LIBER ✦

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Scribed by Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; Cindy P. Farley; Charles Webb; David R. Spigel; John D. Hainsworth

Book ID: 119934814
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 120 KB
Volume: 9
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2009.n.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Weekly Vinorelbine a

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

A phase II trial of weekly docetaxel and

A phase II trial of weekly docetaxel and trastuzumab in metastatic breast cancer

✍ A. Taran; K. Wollschlaeger; B. Bliimel; E. Kettner; S.D. Costa; J. Bischoff 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Multicenter phase II trial of three-week

Multicenter phase II trial of three-weekly docetaxel and weekly trastuzumab in HER-2-overexpressing metastatic breast cancer patients: Japan East cancer center breast cancer consortium (JECBC 01 trial)

✍ T Tabei; M Kimura; M Sano; T Asaga; J Ando; H Fujii; N Yamamoto; M Kurosumi; K I 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Randomized phase III trial of trastuzuma

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

Trastuzumab with either docetaxel or vin

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

✍ Stefania Redana; Michela Donadio; Franco Nolè; Maria Elena Jacomuzzi; Alessandra 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 309 KB

Randomized Phase II Trial of weekly pacl

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

✍ Giampietro Gasparini; Massimo Gion; Luigi Mariani; Paola Papaldo; Diana Crivella 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 222 KB